Immune checkpoint inhibitor-induced autoimmune encephalitis in metastatic squamous cell lung cancer

Because of their efficacy in improving prognosis, immune checkpoint inhibitors (ICIs) are widely used in patients with non-small-cell lung cancer. However, approximately half of patients experience immune-related adverse events, including autoimmune encephalitis, during treatment. Herein the authors...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Immunotherapy 2023-04, Vol.15 (6), p.409-416
Hauptverfasser:	Wang, Junhui, Zheng, Qinhong, Chen, Jianxin
Format:	Artikel
Sprache:	eng
Schlagworte:	adverse event Aged Autoimmune Diseases of the Nervous System - chemically induced autoimmune encephalitis Carcinoma, Non-Small-Cell Lung - drug therapy Carcinoma, Squamous Cell - drug therapy Humans immune checkpoint inhibitors Immune Checkpoint Inhibitors - adverse effects Immune Checkpoint Inhibitors - therapeutic use Lung Neoplasms - drug therapy Lung Neoplasms - pathology Male Neoplasm Metastasis squamous cell lung cancer Tomography, X-Ray Computed treatment
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!